Status:

COMPLETED

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome

Lead Sponsor:

Université Catholique de Louvain

Conditions:

Human Volunteers

Eligibility:

MALE

18-80 years

Phase:

PHASE1

Brief Summary

Muscular compartment syndrome (MCS) is consecutive to an increase in intramuscular compartment pressures, and is a rare but serious postoperative complication. The INVOS (In Vivo Optical Spectroscopy...

Detailed Description

After inflation of a tourniquet (pressure equal to the mean arterial pressure, we will obtain a model of slight venous congestion and arterial hypoperfusion. A comparison will be made between INVOS mo...

Eligibility Criteria

Inclusion

  • Healthy volunteers
  • \>18yr
  • Informed consent
  • Male

Exclusion

  • Neuropathies
  • Vascular pathology
  • Actual pain
  • Anti-platelet or anticoagulant therapy
  • Ipsilateral history of fracture

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2011

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT01452425

Start Date

October 1 2011

End Date

December 1 2011

Last Update

December 22 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cliniques universitaires Saint-Luc

Brussels, Belgium, 1200

In Vivo Optical Spectroscopy Monitoring in a New Model of Muscular Compartment Syndrome | DecenTrialz